Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome after relapse in childhood acute lymphoblastic leukemia.
Yumura-Yagi K, Hara J, Horibe K, Tawa A, Komada Y, Oda M, Nishimura S, Yoshida M, Kudo T, Ueda K; Japan Association of Childhood Leukemia Study. Yumura-Yagi K, et al. Int J Hematol. 2002 Jul;76(1):61-8. doi: 10.1007/BF02982720. Int J Hematol. 2002. PMID: 12138898
Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia.
Usami I, Imamura T, Takahashi Y, Suenobu SI, Hasegawa D, Hashii Y, Deguchi T, Hori T, Shimada A, Kato K, Ito E, Moriya-Saito A, Kawasaki H, Hori H, Yumura-Yagi K, Hara J, Sato A, Horibe K; Japan Association of Childhood Leukemia Study Group (JACLS). Usami I, et al. Among authors: yumura yagi k. Int J Hematol. 2019 Apr;109(4):477-482. doi: 10.1007/s12185-019-02599-w. Epub 2019 Jan 28. Int J Hematol. 2019. PMID: 30689137
Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
Suzuki N, Yumura-Yagi K, Yoshida M, Hara J, Nishimura S, Kudoh T, Tawa A, Usami I, Tanizawa A, Hori H, Ito Y, Miyaji R, Oda M, Kato K, Hamamoto K, Osugi Y, Hashii Y, Nakahata T, Horibe K; Japan Association of Childhood Leukemia Study (JACLS). Suzuki N, et al. Pediatr Blood Cancer. 2010 Jan;54(1):71-8. doi: 10.1002/pbc.22217. Pediatr Blood Cancer. 2010. PMID: 19813250
Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study.
Hori H, Kudoh T, Nishimura S, Oda M, Yoshida M, Hara J, Tawa A, Usami I, Tanizawa A, Yumura-Yagi K, Kato K, Kobayashi R, Komada Y, Matsuo K, Horibe K; Japan Association of Childhood Leukemia Study. Hori H, et al. Among authors: yumura yagi k. Int J Clin Oncol. 2017 Apr;22(2):387-396. doi: 10.1007/s10147-016-1062-1. Epub 2016 Nov 17. Int J Clin Oncol. 2017. PMID: 27858183 Clinical Trial.
Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.
Horibe K, Yumura-Yagi K, Kudoh T, Nishimura S, Oda M, Yoshida M, Komada Y, Hara J, Tawa A, Usami I, Tanizawa A, Kato K, Kobayashi R, Matsuo K, Hori H; Japan Association of Childhood Leukemia Study (JACLS), Japan. Horibe K, et al. Among authors: yumura yagi k. J Pediatr Hematol Oncol. 2017 Mar;39(2):81-89. doi: 10.1097/MPH.0000000000000760. J Pediatr Hematol Oncol. 2017. PMID: 28169879 Clinical Trial.
JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia.
Takahashi Y, Ishida H, Imamura T, Tamefusa K, Suenobu S, Usami I, Yumura-Yagi K, Hasegawa D, Nishimura S, Suzuki N, Hashii Y, Deguchi T, Moriya-Saito A, Kosaka Y, Kato K, Kobayashi R, Kawasaki H, Hori H, Sato A, Kudo T, Nakahata T, Oda M, Hara J, Horibe K. Takahashi Y, et al. Among authors: yumura yagi k. Int J Hematol. 2022 Jun;115(6):890-897. doi: 10.1007/s12185-022-03315-x. Epub 2022 Mar 8. Int J Hematol. 2022. PMID: 35258855
Intensification of chemotherapy using block therapies as consolidation and reinduction therapies for acute lymphoblastic leukemia during childhood.
Hara J, Park YD, Yoshioka A, Yumura-Yagi K, Koudera U, Hosoi G, Sako M, Kosaka Y, Sano K, Misu H, Mabuchi O, Aoyagi N, Yamamoto M, Tawa A, Miyata H, Tanaka H, Kikkawa M, Shimodera M, Kawa-Ha K; Osaka Childhood Leukemia Study Group. Hara J, et al. Int J Hematol. 2001 Aug;74(2):165-72. doi: 10.1007/BF02982000. Int J Hematol. 2001. PMID: 11594517
52 results